Dr. Barry Ginsburg, a Birmingham, AL based Dermatologist today announced his practice is the first in the state to offer the Cellulaze™ by Cynosure, the world's first and only minimally invasive medical device designed to treat women who have struggled to eliminate cellulite through diet and exercise, or have tried the myriad of lotions and creams currently on the market. "Those treatments cannot compare to Cellulaze procedure which directly treats the physiological structure of cellulite, providing clinically proven, results," said Cynosure President and Chief Executive Officer Michael Davin.
Cellulite is made up of fat just beneath the surface of the skin, around the hips, thighs, and buttocks, which produces an "orange-peel" or a "cottage cheese" appearance. Dr. Ginsburg, having over 20 years of experience with dermatologic and minimally invasive cosmetic procedures, is continually seeking the most advanced treatments for his patients. "In Birmingham, Liposuction has been the primary treatment for removal of fat under the skin. The Cellulaze laser is the world's first one-time treatment for cellulite that is FDA approved. Cellulaze reduces cellulite in just one treatment by restoring the normal structure of the skin and underlying connective tissue. Cellulaze diminishes the lumpy pockets of fat, releases the areas of skin depression typifying cellulite and increases the elasticity and thickness of the skin. Nearly four years of clinical research puts Cellulaze in a class of its own: the only single-treatment aesthetic procedure clinically shown to reduce cellulite. Clinical data has demonstrated that Cellulaze treatments can increase the thickness of the skin by 25% and increase the elasticity of the skin by 29% at one year. No other anti-cellulite treatment has been proven to deliver these results.
"I want results for my patients and, after seeing the this procedure, I had to have it for my practice." Said Dr. Ginsburg. "We recommend patients thinking of this procedure come for a free consultation and join us for our seminars on the new Cellulaze procedure."